Semus Wealth Partners LLC Decreases Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Semus Wealth Partners LLC lowered its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 10.3% in the 3rd quarter, Holdings Channel.com reports. The firm owned 4,725 shares of the company’s stock after selling 541 shares during the quarter. Semus Wealth Partners LLC’s holdings in Procter & Gamble were worth $818,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Concurrent Investment Advisors LLC grew its stake in shares of Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after acquiring an additional 4,035 shares during the period. Radnor Capital Management LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at approximately $5,705,000. Welch Group LLC grew its stake in shares of Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after acquiring an additional 2,990 shares during the period. GAMMA Investing LLC grew its stake in shares of Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after acquiring an additional 10,777 shares during the period. Finally, Curi RMB Capital LLC grew its stake in shares of Procter & Gamble by 20.3% during the 3rd quarter. Curi RMB Capital LLC now owns 21,655 shares of the company’s stock valued at $3,751,000 after acquiring an additional 3,652 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insiders Place Their Bets

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This trade represents a 25.95 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jon R. Moeller sold 31,797 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $5,380,688.34. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares of the company’s stock, valued at approximately $50,897,483.94. This represents a 9.56 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 313,597 shares of company stock valued at $53,268,499. 0.18% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

PG has been the subject of several recent analyst reports. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research note on Thursday, August 29th. JPMorgan Chase & Co. upped their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Piper Sandler initiated coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price target for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. Finally, DA Davidson upped their price target on Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research note on Monday, October 21st. Nine equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $177.00.

Procter & Gamble Price Performance

Shares of PG stock opened at $169.12 on Monday. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The stock’s 50-day moving average is $170.32 and its 200 day moving average is $168.40. The company has a market cap of $398.28 billion, a P/E ratio of 29.23, a PEG ratio of 3.67 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter last year, the company earned $1.83 earnings per share. The firm’s revenue for the quarter was down .6% compared to the same quarter last year. Research analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.38%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.